Your session is about to expire
← Back to Search
Tozorakimab for COPD (PROSPERO Trial)
PROSPERO Trial Summary
This trial studies safety & effectiveness of a new COPD treatment. Subjects may be offered a chance to join an extension study.
PROSPERO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PROSPERO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I regularly take or will need to take medication that affects my immune system.I am able to understand and sign the consent form.I can follow all study requirements and procedures.You have had a serious allergic reaction to any type of antibody therapy in the past.Women who could become pregnant must have a negative urine pregnancy test at the first visit.
- Group 1: Tozorakimab Dose 1
- Group 2: Tozorakimab Dose 2
- Group 3: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age range for this trial limited, and if so what are its upper limits?
"Adhering to the parameters of entry, individuals aged 40 and over but less than 130 can enroll in this medical trial."
How hazardous is the first dosage of Tozorakimab for patients?
"Our evaluations place Tozorakimab Dose 1's safety at 3, due to the presence of multiple rounds of data confirming efficacy and supporting data for its security."
In what geographical areas can this clinical trial be accessed?
"This study is currently enrolling patients at 10 sites, including the cities of Newport Beach, Pensacola and Tampa. To reduce travel requirements for potential participants, it may be prudent to choose a medical site close by."
Are there any remaining openings in this clinical research endeavor?
"As detailed on clinicaltrials.gov, this clinical trial has stopped recruiting participants at present. Initially posted on February 20th 2023 and last updated on the 15th of that same month, there are 472 other research studies actively seeking patients to join their trials right now."
Are there any criteria restricting participation in this experiment?
"This medical study is enrolling 2544 individuals aged 40 to 130 with chronic obstructive pulmonary disease. To be considered, applicants must have completed the treatment period of predecessor studies within 12 weeks prior and provide a negative urine pregnancy test result. Additionally, female participants need to attest that they are using contraception as agreed in earlier trials before being accepted into this research program. Ultimately, all potential participants must sign an informed consent document to qualify for involvement."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger